It is, however, a sad reflection on the standards of some investigators that the only motivation that can be identified for their committing forgery or fraud is straightforward greed. Many acts of fraud in clinical research have been linked to trivial studies involving small sums of money. It is therefore difficult to understand how greed could be a motivating factor. Further analysis does, however, show that quite often the company has conveyed the idea that these studies are trivial (occasionally postmarketing surveillance is the culprit here) and this has communicated itself to the investigator. The unscrupulous investigator feels, therefore, that as the study is trivial he will treat it trivially and has a licence to defraud.
It is obvious that company culture, approach, and attitude, or academia's approach and attitude, are common factors. In tackling the problem of fraud, it therefore seems that a change in attitude on behalf of the company or academia should be the key to success.
Was this article helpful?